Influenza: state-of-the-art and vaccination during COVID-19 pandemic
Despite the COVID-19 pandemic, seasonal infections, in particular the influenza virus, are still in our reality. We have discussed with Dmitry Lioznov, the acting head of Smorodintsev Research Institute of Influenza, how the pandemic has changed the influenza vaccination rates and state-of-the-art i...
Saved in:
| Main Author: | Editorial Article |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024
by: Emi Takashita, et al.
Published: (2025-05-01) -
Clinical efficacy of baloxavir marboxil versus oseltamivir in kidney transplant recipients with influenza
by: Jiali Jiang, et al.
Published: (2025-07-01) -
Safety evaluation of baloxavir marboxil: analysis and discussion utilizing real adverse events from the FAERS database
by: Xiaolong Lai, et al.
Published: (2025-05-01) -
Innovations in the treatment and prevention of influenza in children and adolescents
by: Yu. V. Lobzin, et al.
Published: (2024-12-01) -
Validation of chromatographic method for impurity profiling of Baloxavir marboxil (Xofluza)
by: Wang Yiyun, et al.
Published: (2025-03-01)